Stock Scorecard
Stock Summary for Nutex Health Inc (NUTX) - $213.02 as of 10/8/2026 5:09:19 AM EST
Total Score
14 out of 30
Safety Score
40 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for NUTX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NUTX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NUTX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NUTX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NUTX (40 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 8 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for NUTX
Financial Details for NUTX
Company Overview |
|
|---|---|
| Ticker | NUTX |
| Company Name | Nutex Health Inc |
| Country | N/A |
| Description | Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL CARE FACILITIES |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | 11/18/2026 |
Stock Price History |
|
| Last Day Price | 213.02 |
| Price 4 Years Ago | 285.00 |
| Last Day Price Updated | 10/8/2026 5:09:19 AM EST |
| Last Day Volume | 236,979 |
| Average Daily Volume | 161,916 |
| 52-Week High | 226.16 |
| 52-Week Low | 83.99 |
| Last Price to 52 Week Low | 153.63% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 49.51 |
| Sector PE | 38.56 |
| 5-Year Average PE | -49.35 |
| Free Cash Flow Ratio | 7.11 |
| Industry Free Cash Flow Ratio | 34.96 |
| Sector Free Cash Flow Ratio | 32.29 |
| Current Ratio Most Recent Quarter | 5.00 |
| Total Cash Per Share | 29.97 |
| Book Value Per Share Most Recent Quarter | 57.62 |
| Price to Book Ratio | 3.50 |
| Industry Price to Book Ratio | 23.74 |
| Sector Price to Book Ratio | 8.69 |
| Price to Sales Ratio Twelve Trailing Months | 1.77 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.06 |
| Sector Price to Sales Ratio Twelve Trailing Months | 8.43 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 6,848,000 |
| Market Capitalization | 1,458,760,960 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 95.90% |
| Annual Earnings Growth | 35.67% |
| Reported EPS 12 Trailing Months | 25.24 |
| Reported EPS Past Year | 15.32 |
| Reported EPS Prior Year | 16.39 |
| Net Income Twelve Trailing Months | 179,918,000 |
| Net Income Past Year | 70,789,000 |
| Net Income Prior Year | 52,179,168 |
| Quarterly Revenue Growth YOY | -13.60% |
| 5-Year Revenue Growth | 26.14% |
| Operating Margin Twelve Trailing Months | 57.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 205,208,000 |
| Total Cash Past Year | 185,574,000 |
| Total Cash Prior Year | 43,581,412 |
| Net Cash Position Most Recent Quarter | 174,103,000 |
| Net Cash Position Past Year | 156,400,000 |
| Long Term Debt Past Year | 29,174,000 |
| Long Term Debt Prior Year | 22,465,896 |
| Total Debt Most Recent Quarter | 31,105,000 |
| Equity to Debt Ratio Past Year | 0.92 |
| Equity to Debt Ratio Most Recent Quarter | 0.93 |
| Total Stockholder Equity Past Year | 329,447,000 |
| Total Stockholder Equity Prior Year | 146,344,749 |
| Total Stockholder Equity Most Recent Quarter | 394,316,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 274,169,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 40.04 |
| Free Cash Flow Past Year | 245,599,000 |
| Free Cash Flow Prior Year | 20,849,910 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 2.00 |
| RSI | 0.00 |
| 50-Day SMA | 81.70 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 90.00 |
System |
|
| Modified | 10/9/2026 5:48:18 AM EST |